 - treatment with systemic or locally acting medications which might have countered or influenced the trial aim medications which are known to provoke or aggravate psoriasis, e.g. antimalarial drugs, lithium within eight weeks before first treatment andor during the trial. Beta-blockers or angiotensin-converting enzyme ACE inhibitors are allowed if on a stable dose for 3 months before study medication initiation; 